Market Mover: Nature`s Sunshine Products, (NATR) Rises at Midday May 13

Equities Staff  |

Nature`s Sunshine Products, Inc. (NASDAQ: NATR) has risen $0.56 (4.55%) and sits at $12.72, as of 11:56:35 est on May 13.

13,296 shares have traded hands.

The Company is down 21.59% over the last 5 days and shares lost 29.74% over the last 30 days.

Nature`s Sunshine Products, is set to release earnings on 2022-08-04.

For technical charts, analysis, and more on Nature`s Sunshine Products, visit the company profile.

About Nature`s Sunshine Products, Inc.

Nature's Sunshine Products, a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety and efficacy on the market today.

To get more information on Nature`s Sunshine Products, Inc. and to follow the company's latest updates, you can visit the company's profile page here: Nature`s Sunshine Products, Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I
Bumble Beats First Quarter Estimates, Has Over 3 Million Paying Users
Squarespace Beats Revenue Estimates With Record Q1
BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb Worth up to $905 Million
How To Trade in a Bearish Market
AbbVie and Teva Weighing $5 Billion Opioid Lawsuit Settlement

Market Movers

Sponsored Financial Content